References:
1. Maisch B, Seferović PM, Ristić AD, et al. Guidelines on the diagnosis
and management of pericardial diseases executive summary; The Task force
on the diagnosis and management of pericardial diseases of the European
society of cardiology. Eur Heart J . 2004;25(7):587-610.
doi:10.1016/j.ehj.2004.02.002
2. Baracco GJ. 2018. Infections caused by group C and G streptococcus
(Streptococcus dysgalactiae subsp. equisimilis and others):
epidemiological and clinical aspects. Microbiol Spectrum
7(2):GPP3-0016-2018. doi:10.1128/microbiolspec.GPP3- 0016-2018.
3. Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial
diseases: part II: Noninfectious pericarditis, pericardial effusion and
constrictive pericarditis. J Cardiovasc Med (Hagerstown) .
2010;11(11):785-794.
4. Yu X, Jia N, Ye S, Zhou M, Liu D. Primary chylopericardium: A case
report and literature review. Exp Ther Med . 2018;15(1):419-425.
doi:10.3892/etm.2017.5383
5. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the
diagnosis and management of pericardial diseases: The Task Force for the
Diagnosis and Management of Pericardial Diseases of the European Society
of Cardiology (ESC)Endorsed by: The European Association for
Cardio-Thoracic Surgery (EACTS). Eur Heart J .
2015;36(42):2921-2964. doi:10.1093/eurheartj/ehv318
6. Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International
collaborative systematic review of controlled clinical trials on
pharmacologic treatments for acute pericarditis and its recurrences.American Heart Journal . 2010;160(4):662-670.
doi:10.1016/j.ahj.2010.06.015
7. Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. Colchicine for
pericarditis. Cochrane Database Syst Rev . 2014;(8):CD010652.
doi:10.1002/14651858.CD010652.pub2
8. Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent
pericarditis: high versus low doses: a nonrandomized observation.Circulation . 2008;118(6):667-671.
doi:10.1161/CIRCULATIONAHA.107.761064
9. Oppegaard O, Mylvaganam H, Skrede S, Lindemann PC, Kittang BR.
Emergence of a Streptococcus dysgalactiae subspecies equisimilis
stG62647 -lineage associated with severe clinical manifestations.Scientific Reports . 2017;7(1):7589.
doi:10.1038/s41598-017-08162-z